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A total of 70 ear and nasal swab samples collected from 35 persons, 16-hospital population and 19 non-
hospital population was examined for presence of Staphylococcus aureus. Eighty percent of the 
population studied were found to be carriers of S. aureus. Of the 28 positive cases, 35.7% were carriers 
of S. aureus in both the ear and nostrils, while 14.3% and 50.0% had it only in their ear and nostrils, 
respectively. The S. aureus isolates varied in their antibiotic susceptibility pattern when tested for their 
sensitivity to 16 antibiotics. Eighty percent of the isolates were resistant to more than one antimicrobial 
agent. All the isolates showed resistance to nalidixic acid and 100% sensitivity to rifampicin.  
 





Staphylococcus aureus is a Gram-positive, catalase 
positive, coagulase positive, non-motile coccus bacterium 
that causes a variety of human infection in all age groups 
(Boyce, 1981). It is the major causative agent in surgical 
wound infections and epidermal skin diseases in newborn 
infants (Baldwin et al., 1957). S. aureus infection may 
also be superimposed on superficial dermatological 
diseases such as eczema, pediculosis and mycosis 
(Kloos and Bannerman, 1995). They live as commensals 
in anterior naves of over half the population of humans 
(Doig, 1981). The cocci are spread from these sites into 
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dust. S. aureus is an opportunistic pathogen in the sense 
that it causes infection most commonly in tissues and 
sites with lowered host resistance such as in individuals 
with diabetes, old malnourished persons and other 
chronic cases (Burnett et al., 1996). 
S. aureus causes folliculitis, boil, furnculosis, scalded 
skin syndrome, conjunctivitis, paronychia, mastitis, and 
toxic shock syndrome for menstruating women who use 
tampons. Staphylococcal pneumonia can occur if 
staphylococcal infection spreads to the lungs 
(Klodkowska-Farner, et al., 1995).Hospital acquired 
Staphylococcal infections are common in newborn 
babies, surgical patients and hospital staff. Patients 
develop sepsis in operation wounds, which take place in 
the theatre during operation, and others post-operations 
in the ward (Tuo et al., 1995). Staphylococcal food 





the bacteria is ingested with food. Food with a high salt or 
sugar content favours the growth of S. aureus (Tuo et al., 
1995). Many outbreaks of staphylococcal food poisoning 
result from hand contacts (Bryant et al., 1998). 
Attempts to control these diseases by chemotherapy 
through the use of antimicrobial agents particularly 
antibiotics have resulted in increased prevalence of 
resistance to these agents (Levy, 1998). Several 
investigations have been conducted to study the 
antimicrobial resistance pattern of S. aureus and it has 
been shown that the organism is resistant to β-lactam 
antibiotics, amino glycoside and macrolides (Atkinson 
and Lorian, 1984; Maple et al., 1989). S. aureus strains 
carry a wide variety of multi-drug resistant genes on 
plasmids, which can be exchanged and spread among 
different species of Staphylococci (Neihart et al., 1988). 
The multi-resistance determinants can be transferred to 
new bacterial hosts. The situation is made more difficult 
in developing countries such as Nigeria where 
antimicrobial drugs are readily available to consumers 
across the counter with or without prescription from a 
medical practitioner.Such a practice has led to misuse of 
antimicrobial drugs with the associated high prevalence 
of drug resistance among the Staphylococci (Nnochiri, 
1973; Adekeye, 1979; Paul et al., 1982). Hospital strains 
of S. aureus are usually resistant to a variety of different 
antibiotics. Few strains are resistant to all clinically useful 
antibiotics except vancomycin. Some workers have 
reported however the presence of vancomycin resistant 
strains (Aubry-Damon et al., 1998; Shakibaie et al., 
2002). This work was undertaken to determine the 
prevalence of antibiotic resistant S. aureus in hospital 




MATERIALS AND METHOD 
 
Antibiotics and media  
 
Antibiotic discs used and their concentrations were as follows: 
penicillin (30 µg/disc), rifampicin (10 µg/disc), peflacine (10 
µg/disc), streptomycin (30 µg/disc), gentamycin ((10 µg/disc), 
lincomycin (30 µg/disc), ciprofloxacin (10 µg/disc), nalidixic acid (30 
µg/disc), chloramphenicol (25 µg/disc), septrin (cotrimoxazole)  (25 
µg/disc), erythromycin ((25 µg/disc), tetracycline (30 µg/disc), 
ampicillin (25 µg/disc), ampiclox (30 µg/disc), amoxil (Amoxycillin) 
(10 µg/disc), cloxacillin (12.5 µg /disc). Mannitol salt agar and 





Ear and nasal swabs were collected from hospitalized patients and 
staff of Priscilla Hospital and New Era Hospital in Umuahia (referred 
to as Hospital population) and students of Michael Okpara 
University of Agriculture Umudike, Abia State, Nigeria (referred to 
as non-hospital population) using sterile swab sticks (EVEPON). All 
specimens were transported to the laboratory and cultured within 3 
to 4 hours of collection. A total of 70 samples (32 hospital and 38 
non-hospital population) were collected. 




Isolation and characterization of bacteria 
 
The swab specimens were inoculated on mannitol salt agar (Difco) 
and streaked with sterilized wire loop so as to obtain discrete 
colonies. The plates were incubated at 37oC for 24 h under aerobic 
conditions. After 24 h of incubation, the culture plates were 
examined recording the appearance, size, colour, and morphology 
of the colonies. Gram stain reaction, catalase test and coagulase 
test were carried out. Isolates that were gram-positive cocci, 
catalase positive, and coagulated human plasma were considered 
S. aureus in this study. 
 
 
Susceptibility of Isolates to various antibiotics 
 
Antibiotic sensitivity test was carried out on all isolates using paper 
disc diffusion technique. A total of 16 antibiotics shown above were 
tested. A 0.2 ml of 12-h peptone water culture of the test organism 
was used to inoculate on a dry sterile nutrient agar plate. This was 
spread over the entire surface of the nutrient agar using a sterile 
glass spreader and allowed to dry for about 15 to 30 min. The 
antibiotic discs were placed on the agar using sterile forceps. Each 
disc was placed far from each other to avoid their zones of 
inhibition from coalescing into the other. The plates with the 
antibiotic discs were then incubated at 370C for 24 h to observe the 











Hospital 16 14 (87.5%) 
Non-hospital 19 14 (73.7%) 




Table 2. Frequency of isolation of S. aureus from nostril and ear. 
 
Pattern of S. aureus colonization (%)  
Source Ear and 
nostril 
Ear only Nostril only 
Hospital 35.7 14.3 50 






Of 35 persons screened, 80.0% were positive for S. 
aureus. Table 1 shows that out of 16 persons from the 
hospital population (Hp) screened, only 2 did not harbour 
any S. aureus and 14 (87,5%) were colonized either in 
the ear or nostril or both. Out of nineteen persons from 
non-hospital population (NHp), 5 did not harbor any S. 
aureus, while 14 (73.7%) were colonized. In both 
populations, 14 persons each were colonized in ear and 
nostril (Table 2).  




        Table 3. Inhibition zone diameter (IZD) of test antibiotics against different isolates of S. aureus from non-hospital sources. 
 
Antibiogram Code of 
Strains NA CO CP TE PF ST SP LN AP PN GN ER CL RF AX AC PR  
NHP-1E R S+++ S+++ R S++ S+ R S+++ R R R S++ R S+++ R S++ 50 
NHP-1N R R R R R S+ R R S++ R R R R R R R 87.5 
NHP-2E R S++ S+++ R S++ S+ S+ S++ R S+ R S++ R S+++ R S+ 37.5 
NHP-2N R R S++ R R S+ R S+ S+ S+ S+ R S+ S+ R S+ 43.8 
NHP-3E R S+++ S++ R S++ S+ R S++ R S+ S+ S+ S+ S+ R S+ 31.3 
NHP-4E R S+++ S++ S+ S++ R R S+ S+ S+ R S++ R S+ R R 43.8 
NHP-4N R S++ S++ S+ S++ R S+ S+ R S+ S++ S++ R S++ R S+ 31.3 
NHP-5E R S++ S+ R S+ S++ S++ S++ R R S++ R S+ S+ R R 43.8 
NHP-6N R S++ S+ R R S+ R R R R S++ S++ R S+++ R S++ 56.3 
NHP-7N R S+++ S+ S+ S++ S+ R R S+ S+ S+ S+ R S+ R S++ 31.3 
NHP-8N R S++ S+++ S++ S++ S++  S++ S+ R R S+ S++ S+ S++ R S++ 25 
NHP-11N R S++ S++ R S++ S+ R S+ R R S++ S++ R S+++ R S+ 43.8 
NHP-12N R S++ S+ S+ R S++ R S++ R R S+ R R S++ R R 56.3 
NHP-15E R S++ S+++ R S++ S++ R S++ S++ S+ S++ S++ R S++ R S++ 31.3 
NHP-15N R S++ S+ S++ S++ S++ R S+++ S+ R S+++ S+ R S++ R R 37.5 
NHP-16E R S++ S+ S+ S++ S++ R R S+ S++ R R R S+ S+ R 43.8 





































NA, nalidixic acid; CO, cloxacillin; CP, ciprofloxacin; TE, tetracycline; PF, peflacine; SP, septrin; LN, lincomycin; AP, Ampicillin; PN, penicillin; GN, 
gentamycin; ER, erythromycin; ST, streptomycin; CL, chloramphenical; RF, rifampicin; AX, amoxil; AC, ampiclox; PR, percent resistance (%). 
 
0 to 5 mm Resistance (R) 
5 to 15 mm Sensitive (S+) 
15 to 25 mm Sensitive (S++) 




        Table 4. Inhibition zone diameter (IZD) of test antibiotics against different isolates of S. aureus from hospital sources. 
 
Antibiogram Code of 
Strains NA CO CP TE PF ST SP LN AP PN GN ER CL RF AX AC PR 
HP-1E R S++ S++ S+ S+++ S+ S++ S+ R R R S+++ R S+++ R S++ 37.5 
HP-1N R S+++ S+++ S+ S++ S++ S++ S+ S++ R S++ S++ S+ S+++ R S++ 18.8 
HP-2N R S+++ S+++ S+ S+++ S++ S+ S++ S+ R S+++ S++ S+ S+++ S++ S++ 12.5 
HP-3N R S+ R R R S+ R R R S++ S++ R S+ S+ R  S+ 56.3 
HP-4N R R R R S+ R R S+ R R S++ R S+ S+++ R R 68.8 
HP-5E R S++ S++ S+ S++ S+ S++ S+ R S+ S+ R R S++ S++ S++ 25 
HP-5N R R R R S++ S++ R S++ S+ S+ R R R S++ R R 62.5 
HP-7E R R S+ R R S+ R R R R R R R S+ R R 81.3 
HP-7N R S+ R R S+ R R R S+ R S++ R S+ S+ R R 62.5 
HP-8N R S+ R R S+ R R S+ R R S+ S++ R S++ R R 62.5 
HP-9N R R R R S++ R R R R R R R R S+++ R R 87.5 
HP-11E R S++ S++ S+ S++ S++ R S++ S++ S++ S++ S+ R S+++ R S+++ 25 
HP-11N R R S++ R S++ R R S++ R R S+ R R S++ R S+ 62.5 
HP-12N R R R R S+ R R S++ R R R R R S++ R R 81.3 
HP-13E R S+ S++ S+ S+ S+ S+ R R R S++ S+++ S++ S+++ R S+ 31.3 
HP-13N R R S+ R R R R S+++ R R S+ S+ R S+++ R R 68.8 





































NA, nalidixic acid; CO, cloxacillin; CP, ciprofloxacin; TE, tetracycline; PF, peflacine; SP, septrin; LN, lincomycin; AP, Ampicillin; PN, penicillin; GN, 
gentamycin; ER, erythromycin; ST, streptomycin; CL, chloramphenical; RF, rifampicin; AX, amoxil; AC, ampiclox; PR, percent resistance (%). 
 
0 to 5 mm Resistance (R) 
5 to 15 mm Sensitive (S+) 
15 to 25 mm Sensitive (S++) 
25 to 35 mm Sensitive (S+++) 
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The inhibition zone diameter (IZD) range of test 
antibiotics against the different isolates of S. aureus from 
hospital and non-hospital sources are shown in Tables 3 
and 4, respectively. No isolate showed susceptibility to 
nalidixic acid (Na) whereas rifampicin was active against 
all strains. The results are summarized as antibiotic 
sensitivity (S) and resistance (R) pattern for both ear and 
nostril isolates. No strain was sensitive to all 16 
antibiotics; rather there was multiple drug resistance 
ranging from resistance of 2 antibiotics to 14 antibiotics 
(87.5%). Figure 1 represents a summary of the multiple 
drug resistance patterns among hospital and non-hospital 
strains. About 5.26% of hospital strains and 10.53% of 





The carrier rate of S. aureus in this study was 35.7% and 
14.3% for ear and nostril, respectively. There were more 
colonization in nostrils alone (50.0%) followed by both ear 
and nostril (37.5%) and then ear alone (14.3%). The 
nasal carrier rate in this study was higher than what 
earlier workers reported in normal population (Osuide et 
al., 1996). This may be attributed to its function as the air 
passage, making it more prone to dust carrying S. 
aureus. Individuals also touch their nose more frequently 
thereby transferring bacteria from the hand and skin to 
nostril. The ear is colonized by S. aureus less because of 
constant cleaning of the ear with cotton buds, soap and 
water thereby reducing the microbial load. Individuals 
also touch their ear less often than their nose. The carrier 
rate in the male and female were comparable (data not 
shown) indicating that sex is not a notable factor in 
carriage and there is no activity or behavior of any of the 
sexes which predisposes them to S. aureus infection.  
All the isolates of Staph aureus from both hospital and 
non-hospital populations were found to be resistant to 
nalidixic acid. Nalidixic acid is an antibiotic specifically 
use for gram-negative organisms and all strains tested 
were gram-positive, which explains why there seems to 
be a high resistance in all the isolates tested. Rifampicin 
recorded the highest inhibition zone diameter and all the 
isolates were sensitive to it. This high rate of sensitivity 
may be because rifampicin is not in common use and is 
normally used in the treatment of tuberculosis caused by 
Mycobacterium tuberculosis. Cloxacillin, ciprofloxacin, 
peflacine and lincomycin also recorded high sensitivity. 
This may be because they are relatively new and not in 
common use by the population as compared to penicillin, 
chloramphenicol, ampicillin, ampiclox and septrin. 
In this study, the isolates from hospital population 
showed resistance to many antibiotics than isolates from 
non-hospital population, which is similar to previous 
reports (Osuide et al., 1996; Shakibaie et al., 2002). The 
higher prevalence of resistance to anti-microbial agents 
in this environment could be due to widespread, 
indiscriminate use of antibiotics. The formulation and 
implementation of a national drug policy by governments 
are fundamental to ensure rational drug use. Proper use 
of drugs has to be promoted by providing objective 
information and training. 
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